VA111913 TS: First in Human Study

Summary

This is a first-in-human study of VA111913 TS, a new chemical entity being developed for the treatment of dysmenorrhea. This study is designed to investigate determine the safety, tolerability and pharmacokinetics of VA111913 TS after single and multiple doses in healthy non-pregnant female volunteers of child bearing age.

Timeline

Start

2008-09

Primary completion

2009-03

Completion

2009-03

Drugs

Indications